Adaptation of Work in a Hospital and Assessment of Feelings of Quality of Life at Work, Teleworking and Face-to-face (ADAPTAWORK_2)

March 15, 2024 updated by: University Hospital, Clermont-Ferrand

Adaptation of Work in a Hospital Environment and Assessment of Feelings of Quality of Life at Work, Teleworking and Face-to-face

The ADAPTAWORK_2 study is a follow-up to the first qualitative study, to evaluate the feelings of hospital workers in all occupations about teleworking. This involves measuring the variation between three periods: before the COVID-19 pandemic, during the first lockdown an after the pandemic.

Secondary objectives were: 1) to evaluate wich factors were associated to the feelings towards teleworking, 2) to assess musculo-squeletal disorders among teleworkers and the other participants, 3) to assess psycho-social risks among teleworkers and the oher participants, and 4) to evaluate teleworking costs

Study Overview

Status

Completed

Conditions

Detailed Description

This is a quantitative study carried out at the Clermont-Ferrand University Hospital and in the Hospital Centers of the Homogenous Territorial Group (HTG). The target population was made up of all hospital workers in these establishments who agreed to participate and complete the online questionnaire, regardless of their function or grade in the work establishment.

Study Type

Observational

Enrollment (Actual)

945

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Clermont-Ferrand, France
        • CHU de Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Hospital workers

Description

Inclusion Criteria:

  • all hospital workers in the University Hospital Centre of Clermont-Ferrand, and the hospitals belonging to the same HTG who agreed to participate and complete the questionnaire, regardless of their function or grade in the work establishment

Exclusion Criteria:

N/A

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feeling about teleworking
Time Frame: Period 1 of questionnaire= from March 17, 2019 to March 17, 2020; Period 2=from March 18, 2020 to January 18, 2021; Period 3= from January 19, 2021 to January 20, 2024 (study end date).
visual analogic scale (VAS), from 0 (very bad feeling) to 100 (very good feeling) scale
Period 1 of questionnaire= from March 17, 2019 to March 17, 2020; Period 2=from March 18, 2020 to January 18, 2021; Period 3= from January 19, 2021 to January 20, 2024 (study end date).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Musculo-squeletic pain
Time Frame: Period 3= from January 19, 2021 to January 20, 2024 (study end date).
Using the NORDIC questionnaire, participants could express their pain in person or by teleworking
Period 3= from January 19, 2021 to January 20, 2024 (study end date).
psychosocial risks
Time Frame: Period 3= from January 19, 2021 to January 20, 2024 (study end date).
VAS scales from 0 to 100
Period 3= from January 19, 2021 to January 20, 2024 (study end date).
purchases
Time Frame: Period 1 of questionnaire= from March 17, 2019 to March 17, 2020; Period 2=from March 18, 2020 to January 18, 2021; Period 3= from January 19, 2021 to January 20, 2024 (study end date).
self questionnaire about the purchases they have made in order to telework, and the approximate cost of these purchases
Period 1 of questionnaire= from March 17, 2019 to March 17, 2020; Period 2=from March 18, 2020 to January 18, 2021; Period 3= from January 19, 2021 to January 20, 2024 (study end date).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Clermont-Ferrand

Investigators

  • Principal Investigator: Frédéric Dutheil, University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2023

Primary Completion (Actual)

January 20, 2024

Study Completion (Actual)

January 20, 2024

Study Registration Dates

First Submitted

March 6, 2024

First Submitted That Met QC Criteria

March 15, 2024

First Posted (Actual)

March 18, 2024

Study Record Updates

Last Update Posted (Actual)

March 18, 2024

Last Update Submitted That Met QC Criteria

March 15, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024 DUTHEIL ADAPTAWORK_2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

It was not planned to share participants' IDs, which only the investigator is able to know.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Work-Related Condition

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe